Skip to main content

Spentys

ApplicationBrussels, BelgiumFounded 2017· One of 381 Application companies tracked by AMPulse

Spentys provides an end-to-end, AI-powered software platform for the digital design and manufacturing of custom-fit orthotics and prosthetics.

CEO / Founder
Louis-Philippe Broze
Team Size
11-50
Stage
Active
Total Funding
$9.1M
Latest Round
Seed
Key Investors
Invest.BW, welovefounders, SambrInvest, SRIB, Finnance.brussels, Innovation Fund

Technology & Products

Key Products

["Spentys 3D Design Automation Software Platform"]

Technological Advantage

The core advantage is the platform's ability to drastically reduce the time and cost of producing custom orthopedic devices. This allows healthcare providers to scale production, improve patient comfort with lightweight and waterproof designs, and ensure consistent, high-quality clinical outcomes.

Differentiation

Value Proposition

To enable mass customization of orthopedic devices by automating the design and manufacturing workflow, significantly reducing manual labor, improving accuracy, and decreasing patient delivery times.

How They Differentiate

Spentys differentiates itself by focusing on a holistic, user-friendly software platform that automates the entire workflow, rather than just offering a 3D printing service or a single-point solution. This empowers the healthcare providers themselves to produce the devices in-house or through a network.

Market & Competition

Target Customers

Hospitals, orthopedic clinics, and Orthotics & Prosthetics (O&P) professionals.

Industry Verticals

["Healthcare","Medical Devices","Orthopedics"]

Competitors

ActivArmor; Axial3D; Ortho Baltic

Growth & Milestones

Major Milestones

["Co-founder Florian De Boeck named in Forbes 30 Under 30 Europe 2023.","Secured a €2.5M grant from the European Innovation Council (EIC) Accelerator in 2023.","Established key partnerships with industry leaders like HP, BASF, and Materialise to advance digital orthopedics."]

Notable Customers

Case study with HP indicates a focus on clinics utilizing HP's Multi Jet Fusion technology.

https://www.spentys.com

Why this company matters

Spentys provides an end-to-end, AI-powered software platform for the digital design and manufacturing of custom-fit orthotics and prosthetics. The company targets the mass customization gap in orthopedics, where traditional manual design and fabrication are labor-intensive, error-prone, and slow. By automating the entire workflow from 3D scanning to production-ready files, Spentys enables clinics to scale production without requiring in-house technical expertise.

The core product is the Spentys 3D Design Automation Software Platform, a cloud-based solution that integrates scanning, design automation, and file preparation for polymer additive manufacturing. The platform leverages AI to reduce design time and improve accuracy, producing lightweight, waterproof devices with consistent clinical outcomes. It is optimized for HP Multi Jet Fusion technology, as highlighted in a case study with HP, and supports materials from partners like BASF.

Target customers include hospitals, orthopedic clinics, and orthotics and prosthetics (O&P) professionals across Europe. The platform empowers these providers to produce devices in-house or through a network, shifting from a service-bureau model to in-clinic digital production. Key partnerships with HP, BASF, Materialise, and Create it REAL strengthen its ecosystem and market reach.

Spentys differentiates from competitors like ActivArmor, Axial3D, and Ortho Baltic by offering a holistic, user-friendly software platform rather than a single-point solution or printing service. The company raised $9.1M from investors including Invest.BW and the European Innovation Council, which awarded a €2.5M grant in 2023. Co-founder Florian De Boeck was named to Forbes 30 Under 30 Europe in 2023. A key open question is whether the platform can expand beyond polymer MJF into other AM processes or materials as the orthotics market evolves.